Gedeon Richter has provided sponsorship to aid the education of healthcare professionals and improve patient care.
Across Europe, the pharmaceutical industry has announced that from 2016 it would introduce the disclosure of financial relationships beginning with individual payments made to healthcare professionals in 2015.
Gedeon Richter is dedicated to ensuring all our work and activities are delivered to the highest ethical standards and is fully committed to the appropriate use of medicines and the protection of patient safety.
Gedeon Richter UK along with other pharmaceutical companies, will be disclosing details of Transfer of Value (ToV) payments and benefits to individually named HCPs and HCOs on a publicly searchable database, Disclosure UK, which is hosted on the ABPI website.
For details of Gedeon Richter's individual payments to HCPs and HCOs, please click HERE